Publication:
Multidrug Resistant Microorganisms in the Intensive Care Unit without COVID-19 During Pandemic

dc.authorscopusid36844228600
dc.authorscopusid57223242754
dc.authorscopusid36105148600
dc.authorscopusid36479754000
dc.authorscopusid22942100300
dc.contributor.authorKömürcü, Ö.
dc.contributor.authorTaflan, M.G.
dc.contributor.authorBozkurt, I.
dc.contributor.authorÇayci, Y.T.
dc.contributor.authorÜlger, F.
dc.date.accessioned2025-12-11T00:29:59Z
dc.date.issued2022
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kömürcü] Özgür, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Taflan] Mehmet Gökhan, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Bozkurt] Ilkay, Department of Infectious Diseases, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Çayci] Yeliz Tanriverdi, Department of Medical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Ülger] Fatma Esra Bahadır, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractThere are very few reports on the prevalence of multidrug-resistant microorganisms during the COVID-19 pandemic. In addition, these publications usually cover covid-19 patients.Our study aimed to compare the prevalence of multidrug-resistant microorganisms in patients without COVID-19 undergoing treatment in an intensive care unit (ICU) during the COVID-19 pandemic with those in the pre-pandemic period. The study was planned retrospectively. In our country, the prevalence of multi-drug-resistant microorganisms was evaluated in the intensive care unit where internal and surgical patients were hospitalized in a single center in 6-month periods before and after the occurrence of covid-19 cases. The prevalence of multidrug-resistant microorganisms increased in patients being followed up in our ICU during the pandemic period (p<0.05). Statistically significant relationships were found between the incidence rate of microorganisms with multi-drug resistance and sex (p=0.028), presence of malignancy (p=0.011), and nurse's duration of work in the ICU (p=0.04). The increased prevalence of multidrug-resistant microorganisms and the infections caused by these microorganisms are other challenges that must be tackled during the pandemic period. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.39.1.41
dc.identifier.endpage215en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85131969610
dc.identifier.scopusqualityQ4
dc.identifier.startpage210en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.1.41
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36840
dc.identifier.volume39en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronavirus Pandemicen_US
dc.subjectCOVID-19en_US
dc.subjectIntensive Careen_US
dc.subjectMultidrug-Resistant Microorganismsen_US
dc.titleMultidrug Resistant Microorganisms in the Intensive Care Unit without COVID-19 During Pandemicen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files